Federation Des Caisses Desjardins Du Quebec Genmab A/S Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$26.43 - $32.77 $872 - $1,081	33 New	33 $987,000
Q4 2023 Aug 14, 2024	SELL	$27.94 - $35.44 $10,561 - $13,396	-378 Reduced 63.74%	215 $6.85 Million
Q3 2023 Aug 14, 2024	SELL	$35.27 - $42.24 $2,539 - $3,041	-72 Reduced 10.83%	593 $20.9 Million
Q2 2023 Aug 14, 2024	SELL	$37.4 - $42.94 $19,448 - $22,328	-520 Reduced 43.88%	665 $25.3 Million
Q1 2023 Aug 14, 2024	BUY	$34.88 - $43.22 $32,612 - $40,410	935 Added 374.0%	1,185 $44.7 Million
Q4 2022 Aug 14, 2024	BUY	$33.8 - $47.06 $8,450 - $11,765	250 New	250 $10.6 Million
Q4 2021 Aug 30, 2024	SELL	$35.87 - $47.12 $7,173 - $9,424	-200 Closed	0 $0
Q3 2021 Aug 30, 2024	BUY	$41.55 - $48.72 $8,310 - $9,744	200 New	200 $8.74 Million

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

Alliancebernstein L.P. New York, NY

15.1M
Shares

$312 Million
0.13% of portfolio
Black Rock Inc. New York, NY

5.08M
Shares

$105 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

4.42M
Shares

$91 Million
0.02% of portfolio
Harding Loevner LP Bridgewater, NJ

3.07M
Shares

$63.1 Million
0.44% of portfolio
Wellington Management Group LLP Boston, MA

2.31M
Shares

$47.5 Million
0.01% of portfolio

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account